Longenecker John P Phd - Net Worth and Insider Trading
Longenecker John P Phd Net Worth
The estimated net worth of Longenecker John P Phd is at least $474,263 dollars as of 2025-05-07. Longenecker John P Phd is the Director of Pacira BioSciences Inc and owns about 18,823 shares of Pacira BioSciences Inc (PCRX) stock worth over $473,398. Longenecker John P Phd is also the President and CEO of Rein Therapeutics Inc and owns about 500 shares of Rein Therapeutics Inc (RNTX) stock worth over $865. Details can be seen in Longenecker John P Phd's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Longenecker John P Phd has not made any transactions after 2022-03-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Longenecker John P Phd
Longenecker John P Phd Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Longenecker John P Phd owns 2 companies in total, including Pacira BioSciences Inc (PCRX) , and Rein Therapeutics Inc (RNTX) .
Click here to see the complete history of Longenecker John P Phd’s form 4 insider trades.
Insider Ownership Summary of Longenecker John P Phd
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
PCRX | Pacira BioSciences Inc | 2022-03-03 | director |
RNTX | Rein Therapeutics Inc | 2018-08-10 | President and CEO |
Longenecker John P Phd Latest Holdings Summary
Longenecker John P Phd currently owns a total of 2 stocks. Among these stocks, Longenecker John P Phd owns 18,823 shares of Pacira BioSciences Inc (PCRX) as of March 3, 2022, with a value of $473,398 and a weighting of 99.82%. Longenecker John P Phd also owns 500 shares of Rein Therapeutics Inc (RNTX) as of August 10, 2018, with a value of $865 and a weighting of 0.18%.
Latest Holdings of Longenecker John P Phd
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PCRX | Pacira BioSciences Inc | 2022-03-03 | 18,823 | 25.15 | 473,398 |
RNTX | Rein Therapeutics Inc | 2018-08-10 | 500 | 1.73 | 865 |
Holding Weightings of Longenecker John P Phd
Longenecker John P Phd Form 4 Trading Tracker
According to the SEC Form 4 filings, Longenecker John P Phd has made a total of 2 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Pacira BioSciences Inc is the sale of 7,000 shares on March 3, 2022, which brought Longenecker John P Phd around $502,180.
According to the SEC Form 4 filings, Longenecker John P Phd has made a total of 0 transactions in Rein Therapeutics Inc (RNTX) over the past 5 years. The most-recent trade in Rein Therapeutics Inc is the acquisition of 500 shares on August 10, 2018, which cost Longenecker John P Phd around $24,500.
Insider Trading History of Longenecker John P Phd
- 1
Longenecker John P Phd Trading Performance
GuruFocus tracks the stock performance after each of Longenecker John P Phd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Longenecker John P Phd is -12.25%. GuruFocus also compares Longenecker John P Phd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Longenecker John P Phd within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Longenecker John P Phd's insider trading performs compared to the benchmark.
Performance of Longenecker John P Phd
Longenecker John P Phd Ownership Network
Ownership Network List of Longenecker John P Phd
Ownership Network Relation of Longenecker John P Phd

Longenecker John P Phd Owned Company Details
What does Pacira BioSciences Inc do?
Who are the key executives at Pacira BioSciences Inc?
Longenecker John P Phd is the director of Pacira BioSciences Inc. Other key executives at Pacira BioSciences Inc include Chief Clinical Officer Jonathan Slonin , Chief Operating Officer Daryl Gaugler , and CAO and General Counsel Kristen Marie Williams .
Pacira BioSciences Inc (PCRX) Insider Trades Summary
Over the past 18 months, Longenecker John P Phd made no insider transaction in Pacira BioSciences Inc (PCRX). Other recent insider transactions involving Pacira BioSciences Inc (PCRX) include a net sale of 9,672 shares made by Jonathan Slonin , a net purchase of 8,312 shares made by Marcelo Bigal , and a net sale of 2,000 shares made by Daryl Gaugler .
In summary, during the past 3 months, insiders sold 0 shares of Pacira BioSciences Inc (PCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 143,297 shares of Pacira BioSciences Inc (PCRX) were sold and 20,976 shares were bought by its insiders, resulting in a net sale of 122,321 shares.
Pacira BioSciences Inc (PCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pacira BioSciences Inc Insider Transactions
Longenecker John P Phd Mailing Address
Above is the net worth, insider trading, and ownership report for Longenecker John P Phd. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Longenecker John P Phd's mailing address is: San Diego Ca 92121.